Tap on and choose 'Add to Home Screen' to create a shortcut app

Tap on and choose 'Add to Home Screen/Install App' to create a shortcut app

Adjuvant Therapies for Ependymomas in Children

This page was last updated on January 25th, 2023


  • Originally used in children under 3 years: Chemotherapy was originally considered for children younger than 3 years to defer onset of radiation therapy (17).
  • Limited role at present: Cisplastin has a high response rate but little effect on survival. It is not a favored treatment now because tumors that progress during chemotherapy do not respond well to subsequent radiation, and a combination of chemotherapy and radiation does not improve overall survival (18). However, its use may make residual tumor more amenable to second-stage resection.


Current standard adjuvant therapy

  • Early (or immediate) postoperative radiation therapy improves outcome.
  • Improves survival: Patients who underwent surgery plus postoperative radiation had better overall survival rates and progression-free survival rates compared to those who had surgery alone (19).
  • Prophylactic craniospinal radiation is not beneficial.

Conformal radiation therapy

  • Present standard of care, compared to previous conventional radiotherapy: Conformal radiation therapy offers the best local control, event-free survival, and overall survival rates. It can be safely used to treat children younger than 3 years (20, 21).
  • Protective of surrounding tissue: The highest doses of radiation are limited to the primary site, and the dose to normal tissue is decreased. The radiation is focused on residual tumor volume with a 10-mm tumor margin.

Deferring radiation

  • Historical approach: Several studies in the past (with small numbers of patients) advocated deferment of radiation if gross total resection had been achieved, or if the child was younger than 3 years (3, 4, 12).
  • Risk requiring reoperation: However, 20–30% of the tumors recurred within 2 years and required repeat surgery and then radiation.
  • Close radiological surveillance: Close radiological surveillance is required if radiation is deferred.


No role exists for immunotherapy at present.

Your donations keep us going

The ISPN Guide is free to use, but we rely on donations to fund our ongoing work and to maintain more than a thousand pages of information created to disseminate the most up-to-date knowledge in the field of paediatric neurosurgery.

By making a donation to The ISPN Guide you are also indirectly helping the many thousands of children around the world whose treatment depends on well-informed surgeons.

Please consider making a donation today.

Use the app

The ISPN Guide can be used as a standalone app, both on mobile devices and desktop computers. It’s quick and easy to use.

Fully featured

Free registration grants you full access to The Guide and host of featured designed to help further your own education.

Stay updated

The ISPN Guide continues to expand both in breadth and depth. Join our mailing list to stay up-to-date with our progress.